Adagen Global Market Report 2025

Adagen Global Market Report 2025 ) – By Product (Pre-filled, Vial), By Clinical Indication (Severe Combined Immunodeficiency (SCID), Other Rare Genetic Disorders), By End User (Hospitals And Healthcare Institutions, Specialty Clinics, Home Healthcare Services, Research Institutions) – Market Size, Trends, And Global Forecast 2025-2034

Name: Adagen Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Adagen Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Adagen Market Definition

Adagen is a brand name for pegademase bovine, an enzyme replacement therapy used to treat severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency. It is used for supporting immune function in individuals with SCID, helping to reduce the risk of life-threatening infections by replenishing the missing enzyme necessary for proper immune system development.

The main products in adagen are pre-filled and vial. Pre-filled refers to a form of the medication that is supplied in a ready-to-use syringe or device, ensuring convenience and precise dosing for patients. It is primarily used for treating clinical indications such as severe combined immunodeficiency (SCID) and other rare genetic disorders. adagen is employed across various settings, including hospitals and healthcare institutions, specialty clinics, home healthcare services, and research institutions.

Adagen Market Segmentation

The adagenmarket covered in this report is segmented –

1) By Product: Pre-filled, Vial

2) By Clinical Indication: Severe Combined Immunodeficiency (SCID), Other Rare Genetic Disorders

3) By End User: Hospitals And Healthcare Institutions, Specialty Clinics, Home Healthcare Services, Research Institutions

Adagen Market Size and growth rate 2025 to 2029: Graph

Adagen Market Size 2025 And Growth Rate

The adagen market size has grown strongly in recent years. It will grow from $88.58 million in 2024 to $94.94 million in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased diagnosis of severe combined immunodeficiency (SCID), rise in healthcare expenditure in developed countries, strong regulatory support for orphan drugs, increased government focus on rare diseases, and expansion of specialty drug programs.

Adagen Market Growth Forecast

The adagen market size is expected to see strong growth in the next few years. It will grow to $123.58 million in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to ongoing innovation in drug delivery systems, growing healthcare infrastructure in emerging economies, increasing accessibility of enzyme replacement therapies, supportive reimbursement policies, and rising prevalence of genetic disorders. Major trends in the forecast period include the introduction of biosimilar enzyme replacement therapies, a focus on reducing production costs, increasing digitalization in healthcare supply chains, collaboration between biotech firms and academic institutions, and advances in long-acting formulations.

Book your 30 minutes free consultation with our research experts

Adagen Market Driver: Increasing Precision Medicine Adoption Drives Adagen Market's Growth And Demand

The increasing adoption of precision medicine is expected to propel the adagen market going forward. Precision medicine refers to an innovative approach to healthcare that tailors medical treatment and prevention strategies to the individual characteristics of each patient. The adoption of precision medicine is driven by advancements in genomic technologies, increased availability of biomarkers, integration of artificial intelligence in healthcare, and growing demand for targeted therapies tailored to individual genetic profiles. Adagen supports the adoption of precision medicine by offering targeted enzyme replacement therapy specifically designed for patients with severe combined immunodeficiency (SCID) caused by adenosine deaminase deficiency, exemplifying tailored treatments for rare genetic disorders. For instance, in February 2024, according to the data from the Personalized Medicine Coalition (PMC), a US-based nonprofit umbrella organization, reported in 2023, the FDA approved 16 new personalized treatments for rare diseases, a significant increase from six approvals in 2022. Therefore, the increasing adoption of precision medicine is propelling the adagen market.

Adagen Market Driver: Growing Diagnosis Of Rare Diseases Drives Adagen Market Expansion And Awareness

The growing diagnosis of rare diseases is expected to propel the adagen market going forward. Rare diseases are medical conditions that affect fewer than 1 in 2,000 people, often characterized by genetic origins and significant health impacts. The growing diagnosis of rare diseases is driven by advancements in genetic testing technologies, increased awareness among healthcare professionals, improved healthcare infrastructure, and expanded global collaboration in rare disease research. Adagen contributes to the growing diagnosis of rare diseases by providing targeted enzyme replacement therapy for severe combined immunodeficiency (SCID), thereby fostering increased awareness, supporting early diagnosis, and encouraging broader research efforts into rare genetic conditions and their treatments. For instance, in February 2024, according to the Genetic Alliance UK, a UK-based national alliance of organizations, rare conditions, defined as affecting fewer than 1 in 2,000 people, impact over 3.5 million individuals in the UK, with 1 in 17 people experiencing such conditions at some point in their lives. Among the 7,000 identified rare conditions,70% of which affect children and over 30% of affected children die before their fifth birthday due to these severe disorders. Therefore, the growing diagnosis of rare diseases is propelling the adagen market.

Adagen Market Driver: Increasing Healthcare Spending And Demand For Specialized Treatments Drive Adagen's Market

Rising healthcare expenditure is expected to drive the adagen market going forward. Healthcare expenditure refers to the total spending on medical services, treatments, and healthcare infrastructure by individuals, governments, and organizations. Rising healthcare expenditure is driven by factors such as advancements in medical technology, an aging population, increased chronic disease prevalence, demand for specialized treatments, and the overall inflation of medical costs. Adagen contributes to healthcare expenditure by offering specialized enzyme replacement therapy for rare genetic disorders, increasing investment in research, patient care, and treatment access for conditions like severe combined immunodeficiency (SCID). For instance, in September 2024, according to the statistics published by Cross River Therapy, a US-based provider of ABA therapy services, the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021, and projected spending is expected to increase to $605-$635 billion by 2025. Therefore, rising healthcare expenditure is driving the adagen market.

Global Adagen Market Major Players

Major companies operating in the adagen market include Leadiant Biosciences Inc.

Regional Outlook For The Global Adagen Market

North America was the largest region in the adagen market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adagen market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adagen market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Adagen Market?

The adagen market consists of sales of single-use vials and ready-to-use syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adagen Industry?

The adagen market research report is one of a series of new reports from The Business Research Company that provides adagen market statistics, including adagen industry global market size, regional shares, competitors with a adagen market share, detailed adagen market segments, market trends and opportunities, and any further data you may need to thrive in the adagen industry. This adagen market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adagen Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of 6.8% from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Product: Pre-filled, Vial 2) By Clinical Indication: Severe Combined Immunodeficiency (SCID), Other Rare Genetic Disorders 3) By End User: Hospitals And Healthcare Institutions, Specialty Clinics, Home Healthcare Services, Research Institutions
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	Leadiant Biosciences Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Adagen Market Characteristics

3. Adagen Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Adagen Market Trends And Strategies

5. Adagen Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Adagen Growth Analysis And Strategic Analysis Framework

6.1. Global Adagen PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Adagen Market Growth Rate Analysis

6.4. Global Adagen Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Adagen Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Adagen Total Addressable Market (TAM)

7. Global Adagen Market Pricing Analysis & Forecasts

8. Adagen Market Segmentation

8.1. Global Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pre-filled

Vial

8.2. Global Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Severe Combined Immunodeficiency (SCID)

Other Rare Genetic Disorders

8.3. Global Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals And Healthcare Institutions

Specialty Clinics

Home Healthcare Services

Research Institutions

9. Global Adagen Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Adagen Market Regional And Country Analysis

10.1. Global Adagen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Adagen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Adagen Market

11.1. Asia-Pacific Adagen Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Adagen Market

12.1. China Adagen Market Overview

12.2. China Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Adagen Market

13.1. India Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Adagen Market

14.1. Japan Adagen Market Overview

14.2. Japan Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Adagen Market

15.1. Australia Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Adagen Market

16.1. South Korea Adagen Market Overview

16.2. South Korea Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Adagen Market

17.1. Western Europe Adagen Market Overview

17.2. Western Europe Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Adagen Market

18.1. UK Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Adagen Market

19.1. Germany Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Adagen Market

20.1. France Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adagen Market

21.1. Eastern Europe Adagen Market Overview

21.2. Eastern Europe Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Adagen Market

22.1. North America Adagen Market Overview

22.2. North America Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Adagen Market

23.1. USA Adagen Market Overview

23.2. USA Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Adagen Market

24.1. Canada Adagen Market Overview

24.2. Canada Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Adagen Market

25.1. South America Adagen Market Overview

25.2. South America Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Adagen Market

26.1. Middle East Adagen Market Overview

26.2. Middle East Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Adagen Market

27.1. Africa Adagen Market Overview

27.2. Africa Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Adagen Market Competitive Landscape And Company Profiles

28.1. Adagen Market Competitive Landscape

28.2. Adagen Market Company Profiles

28.2.1. Leadiant Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Adagen Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Adagen Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Adagen Market

32. Recent Developments In The Adagen Market

33. Adagen Market High Potential Countries, Segments and Strategies

33.1 Adagen Market In 2029 - Countries Offering Most New Opportunities

33.2 Adagen Market In 2029 - Segments Offering Most New Opportunities

33.3 Adagen Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Adagen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Adagen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Leadiant Biosciences Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Adagen Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Adagen Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Adagen Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Adagen Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Adagen Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Leadiant Biosciences Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the GI drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the oral biologics and biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the ophthalmology drugs market research report 2022 with industry size, share, segments and market growth

Fetal Bovine Serum Global Market Report 2025 – By Product (Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products), By Application (Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications), By End-User (Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Enzyme Inhibitor Global Market Report 2025 – By Type (Proton Pump Inhibitors (PPIs), Protease Inhibitors, Reverse Transcriptase Inhibitors, Aromatase Inhibitors, Kinase Inhibitors, Neuraminidase Inhibitors, Statins, Other Types), By Disease Indication (Chronic Obstructive Pulmonary Disorders, Cardiovascular Disease, Gastrointestinal Disorders, Arthritis, Inflammatory Diseases, Other Disease Indications), By Application (Chemotherapy, Antibiotics, Pesticides, Cardiovascular Treatments, Other Applications), By End User (Pharmaceutical, Biotechnology, Food and Beverage, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Molecular Biology Enzymes & Kits & Reagents Global Market Report 2025 – By Product( Kits and Reagents, Enzymes, Polymerases, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes), By Application( Sequencing, Cloning, PCR, Epigenetics, Restriction Digestion, Other Applications), By End Users( Academic and Research Institutes, Pharmaceutical and Biotechnology companies, Hospitals and Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hydrolase Enzymes Global Market Report 2025 – By Product (Esterase, Glycosylases, Peptidases, Other Products), By Bond Type (Ester Bonds (Esterases), Sugars (DNA Glycosylases And Glycoside Hydrolase), Ether Bonds (Thioether And Trialkylsulfonium), Peptide Bonds (Peptidases), Carbon-Nitrogen Bonds (Other Than Peptide Bonds), Acid Anhydrides, Carbon-Carbon Bonds, Halide Bonds, Phosphorus-Nitrogen Bonds, Other Bond Types), By Application (Pharmaceutical, Food And Beverages, Laundry Detergents, Cosmetics, Textile, Pulp And Paper, Biofuel, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Protein Hydrolysis Enzymes Global Market Report 2025 – By Type (Microorganisms, Animals, Plants), By Method Of Production (Extraction, Fermentation), By Application (Detergent and Cleaning, Food and Beverage, Animal Feed, Textile, Dairy, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Enzyme Replacement Therapy Global Market Report 2025 – By Enzyme Type (Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types), By Route Of Administration (Oral, Parenteral ), By Application (Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications ), By End-Users (Hospitals, Infusion Centers, Other End-Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Diagnostic Enzyme Global Market Report 2025 – By Product Type (Carbohydrases, Polymerases And Nucleases, Protease, Other Product Types), By Source (Animals, Microorganisms, Plants), By Application (Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Specialty Enzymes Global Market Report 2025 – By Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, Oxidase & Hydratases, Other Types), By Source (Microorganisms, Animals, Plants), By Application (Pharmaceutical, Diagnostics, Research & Biotechnology, Food & Beverage, Animal Nutrition, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Adagen market?

How will the Adagen market drivers and restraints affect the market dynamics? What forces will shape the Adagen industry going forward?

The Adagen market major growth driver - Increasing Precision Medicine Adoption Drives Adagen Market's Growth And Demand. For further insights on the Adagen market, request a sample here

What is the forecast market size or the forecast market value of the Adagen market?

The Adagen market size has grown strongly in recent years. The adagen market size has grown strongly in recent years. It will grow from $88.58 million in 2024 to $94.94 million in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased diagnosis of severe combined immunodeficiency (SCID), rise in healthcare expenditure in developed countries, strong regulatory support for orphan drugs, increased government focus on rare diseases, and expansion of specialty drug programs. The adagen market size is expected to see strong growth in the next few years. It will grow to $123.58 million in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to ongoing innovation in drug delivery systems, growing healthcare infrastructure in emerging economies, increasing accessibility of enzyme replacement therapies, supportive reimbursement policies, and rising prevalence of genetic disorders. Major trends in the forecast period include the introduction of biosimilar enzyme replacement therapies, a focus on reducing production costs, increasing digitalization in healthcare supply chains, collaboration between biotech firms and academic institutions, and advances in long-acting formulations. For further insights on the Adagen market, request a sample here

How is the Adagen market segmented?

The adagenmarket covered in this report is segmented –
1) By Product: Pre-filled; Vial
2) By Clinical Indication: Severe Combined Immunodeficiency (SCID); Other Rare Genetic Disorders
3) By End User: Hospitals And Healthcare Institutions; Specialty Clinics; Home Healthcare Services; Research Institutions For further insights on the Adagen market, request a sample here

Which region has the largest share of the Adagen market? What are the other regions covered in the report?

Who are the major players in the Adagen market?

Major companies operating in the adagen market include Leadiant Biosciences Inc. . For further insights on the Adagen market, request a sample here.

What are the key trends in the Adagen market?

Major trends in the Adagen market include . For further insights on the Adagen market, request a sample here.

What are the major opportunities in the Adagen market? What are the strategies for the Adagen market?

For detailed insights on the major opportunities and strategies in the Adagen market, request a sample here.

How does the Adagen market relate to the overall economy and other similar markets?

For detailed insights on Adagen's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Adagen industry?

For detailed insights on the mergers and acquisitions in the Adagen industry, request a sample here.

What are the key dynamics influencing the Adagen market growth? SWOT analysis of the Adagen market.

For detailed insights on the key dynamics influencing the Adagen market growth and SWOT analysis of the Adagen industry, request a sample here.